Abstract
SummaryIn this study the blood survival and organ localization in rats of intravenously injected 51Cr-labeled human erythrocytes was determined in controls and following pretreatment with ethyl palmitate, a cobra venom factor, or both. Organ distribution of labeled cells was consistent with a reticuloendothelial blockade effect for the ethyl palmitate and inhibition of hemolysis for the cobra venom factor. Erythrocyte survival was enhanced only moderately following the injection of either of these substances alone. The combined administration of ethyl palmitate and the cobra venom factor, however, resulted in marked prolongation of human erythrocyte survival consistent with a synergistic effect. This suggests that in the untreated animal, both complement-dependent hemolysis and reticuloendothelial phagocytosis compete for the removal of circulating heterologous erythrocytes. Both must be blocked simultaneously for maximum heterologous erythrocyte survival.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
